Haloperidol and Gynecomastia - a phase IV clinical study of FDA data

Summary:

We study 14,895 people who have side effects when taking Haloperidol. Gynecomastia is found, especially among people who are male, 20-29 old, also take Risperdal and have Agitation.

The phase IV clinical study analyzes which people take Haloperidol and have Gynecomastia. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 29, 2023

14,895 people reported to have side effects when taking Haloperidol.
Among them, 21 people (0.14%) have Gynecomastia.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is used in schizophrenia. Currently, eHealthMe is studying from 15,095 Haloperidol users.

What is Gynecomastia?

Gynecomastia (enlargement of the gland tissue of the male breast) is found to be associated with 1,642 drugs and 629 conditions by eHealthMe. Currently, we are studying 46,942 people who have Gynecomastia.

Number of Haloperidol and Gynecomastia reports submitted per year:

Gender of people who have Gynecomastia when taking Haloperidol *:

female: 0.0 %
male: 100 %

Age of people who have Gynecomastia when taking Haloperidol *:

Common drugs people take besides Haloperidol *:

Common side effects people have besides Gynecomastia *:

Weight Increased: 10 people, 47.62%
Diabetes: 4 people, 19.05%
Emotional Disorder: 4 people, 19.05%
Drug Ineffective: 3 people, 14.29%
Metabolic Syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease): 3 people, 14.29%
Psychotic Disorder: 3 people, 14.29%
Breast Pain: 3 people, 14.29%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 9.52%
Respiratory Depression (respiration has a rate below 12 breaths): 2 people, 9.52%
Parkinson's Disease: 2 people, 9.52%

Common conditions people have *:

Agitation (state of anxiety or nervous excitement): 5 people, 23.81%
Psychotic Disorder: 4 people, 19.05%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 3 people, 14.29%
Sleep Disorder: 2 people, 9.52%
Movement - Uncontrolled Or Slow: 2 people, 9.52%
Depression: 2 people, 9.52%
Stress And Anxiety: 1 person, 4.76%
Schizoaffective Disorder Depressive Type (mental illness featuring schizophrenia and a mood disorder): 1 person, 4.76%
Personality Disorder: 1 person, 4.76%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Haloperidol and have Gynecomastia?

Check whether Gynecomastia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Obayi, O., & Tagbo, N. , "Bilateral Pedal Oedema Associated with Intramuscular Haloperidol–A Rare Observation", International Neuropsychiatric Disease Journal, 2018 Jan .
Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .

Related studies

Haloperidol side effects by duration, gender and age:

Haloperidol side effects (15,095 reports)

Gynecomastia treatments and more:

Gynecomastia (46,942 reports)

Common drugs associated with Gynecomastia:

All the drugs that are associated with Gynecomastia:

Gynecomastia (1,642 drugs)

Common conditions associated with Gynecomastia:

Attention deficit hyperactivity disorder: 10,179 reports
Bipolar disorder: 6,637 reports
Schizophrenia: 4,072 reports
Depression: 3,285 reports
Oppositional defiant disorder: 2,074 reports
Abnormal behavior: 1,376 reports

All the conditions that are associated with Gynecomastia:

Gynecomastia (629 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on haloperidol (the active ingredients of Haloperidol) and Haloperidol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.